Carlisle Companies (CSL) Form 3 CARLISLE COMPANIES / Susan Wallace ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Wallace Susan

(Last) (First) (Middle)

16430 N SCOTTSDALE RD

STE 400

(Street)

SCOTTSDALE AZ 85254

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/04/2024

3. Issuer Name and Ticker or Trading Symbol
CARLISLE COMPANIES INC [ CSL ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
VP & CHRO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	938	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	(1)	01/29/2034	Common Stock	400	320.38	D
Employee Stock Option (Right to Buy)	(2)	01/30/2033	Common Stock	327	250.86	D
Employee Stock Option (Right to Buy)	(3)	02/07/2032	Common Stock	182	222.35	D
Employee Stock Option (Right to Buy)	(4)	02/01/2031	Common Stock	490	150	D
Employee Stock Option (Right to Buy)	(5)	02/03/2030	Common Stock	285	161.41	D

Explanation of Responses:

1. The option vests in three equal annual installments beginning January 30, 2025.

2. The option vests in two equal annual installments beginning January 31, 2025.

3. The option vests on February 8, 2025.

4. 193 options vested on February 2, 2023 and 297 options vested on February 2, 2024.

5. 62 options vested on February 4, 2021, 111 options vested on February 4, 2022 and 112 options vested on February 4, 2023.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	/s/ Susan Wallace by Ronald P. Fuss, attorney-in-fact	12/10/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.